These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 3261539)

  • 21. Anti-Ro/SSA and -La/SSB antibodies in patients with connective tissue diseases.
    Yamagata H; Akizuki M; Tojo T; Homma M
    Scand J Rheumatol Suppl; 1986; 61():98-101. PubMed ID: 3495876
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic studies of anti-Ro (SSA) antibodies in families with rheumatoid arthritis.
    Tishler M; Moutsopoulos HM; Yaron M
    J Rheumatol; 1992 Feb; 19(2):234-6. PubMed ID: 1629820
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Maternal HLA antigens and antibodies to SS-A/Ro and SS-B/La. Comparison with systemic lupus erythematosus and primary Sjögren's syndrome.
    Julkunen H; Siren MK; Kaaja R; Kurki P; Friman C; Koskimies S
    Br J Rheumatol; 1995 Oct; 34(10):901-7. PubMed ID: 7582692
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Frequency of neuro-psychiatric dysfunction in anti-SSA/SSB exposed children with and without neonatal lupus.
    Askanase AD; Izmirly PM; Katholi M; Mumtaz J; Buyon JP
    Lupus; 2010 Mar; 19(3):300-6. PubMed ID: 20008445
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neonatal lupus erythematosus syndrome: late detection of isolated heart block.
    McCarron DP; Hellmann DB; Traill TA; Watson RM
    J Rheumatol; 1993 Jul; 20(7):1212-4. PubMed ID: 8371221
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of the leucocyte immunoglobulin-like receptor A3 (LILRA3) on susceptibility and subphenotypes of systemic lupus erythematosus and Sjögren's syndrome.
    Du Y; Su Y; He J; Yang Y; Shi Y; Cui Y; Luo C; Wu X; Liu X; Hu F; Ma X; Zheng L; Zhang J; Zuo X; Sheng Y; Wu L; Zhang X; Guo J; Li Z
    Ann Rheum Dis; 2015 Nov; 74(11):2070-5. PubMed ID: 24906639
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discordance of SSA/Ro and SSB/La cellular antigens in synchronized cells.
    Elenitsas R; Bair LW; Medsger TA; Deng JS
    J Invest Dermatol; 1986 Oct; 87(4):504-9. PubMed ID: 3531358
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ro(SSA) and La(SSB) antibodies in the clinical spectrum of Sjögren's syndrome.
    Alexander EL; Hirsch TJ; Arnett FC; Provost TT; Stevens MB
    J Rheumatol; 1982; 9(2):239-46. PubMed ID: 7097683
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Neonatal lupus syndrome: Literature review].
    Morel N; Georgin-Lavialle S; Levesque K; Guettrot-Imbert G; Le Guern V; Le Bidois J; Bessières B; Brouzes C; Le Mercier D; Villain E; Maltret A; Costedoat-Chalumeau N
    Rev Med Interne; 2015 Mar; 36(3):159-66. PubMed ID: 25240481
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Subclass distribution of maternal and neonatal anti-Ro(SSA) and La(SSB) antibodies in congenital heart block.
    Tseng CE; Caldwell K; Feit S; Chan EK; Buyon JP
    J Rheumatol; 1996 May; 23(5):925-32. PubMed ID: 8724310
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibodies to Ro and La.
    Reichlin M
    Ann Med Interne (Paris); 1998 Feb; 149(1):34-41. PubMed ID: 11490515
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-Ro/SSA and anti-La/SSB autoantibodies in the tear fluid of patients with Sjögren's syndrome.
    Toker E; Yavuz S; Direskeneli H
    Br J Ophthalmol; 2004 Mar; 88(3):384-7. PubMed ID: 14977774
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recurrent congenital heart block in neonatal lupus.
    Escobar MC; Gómez-Puerta JA; Albert D; Ferrer Q; Girona J
    Clin Rheumatol; 2007 Jul; 26(7):1161-3. PubMed ID: 16586043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular definition of the Ro(SSA) particle(s): a frequent target of autoimmunity in systemic lupus erythematosus and Sjögren's syndrome.
    Reichlin M
    Br J Rheumatol; 1991; 30 Suppl 1():58-62. PubMed ID: 1991243
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical constellation of annular erythema associated with anti-Ro/La autoantibodies.
    Lee CW
    J Korean Med Sci; 2000 Apr; 15(2):199-202. PubMed ID: 10803698
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Significance of the Ro antigen system.
    Reichlin M
    J Clin Immunol; 1986 Sep; 6(5):339-48. PubMed ID: 2429977
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The interaction between anti-Ro/SSA and anti-La/SSB autoantibodies and anti-infectious antibodies in a wide spectrum of auto-immune diseases: another angle of the autoimmune mosaic.
    Agmon-Levin N; Dagan A; Peri Y; Anaya JM; Selmi C; Tincani A; Bizzaro N; Stojanovich L; Damoiseaux J; Cohen Tervaert JW; Mosca M; Cervera R; Shoenfeld Y
    Clin Exp Rheumatol; 2017; 35(6):929-935. PubMed ID: 28770708
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The relationship between anti-Ro (SS-A) antibody-positive Sjögren's syndrome and anti-Ro (SS-A) antibody-positive lupus erythematosus.
    Provost TT; Talal N; Harley JB; Reichlin M; Alexander E
    Arch Dermatol; 1988 Jan; 124(1):63-71. PubMed ID: 3257371
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Antinuclear antibodies, anti-SSA(Ro) and SSB(La) in diffuse connective tissue diseases].
    Assad RL; Gabriel Júnior A; Iglesias SS; Cossermelli W
    Rev Hosp Clin Fac Med Sao Paulo; 1986; 41(3):103-8. PubMed ID: 3551017
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of steroid administration and plasmapheresis to prevent fetal congenital heart block in patients with systemic lupus erythematosus and/or Sjögren's syndrome.
    Makino S; Yonemoto H; Itoh S; Takeda S
    Acta Obstet Gynecol Scand; 2007; 86(9):1145-6. PubMed ID: 17712660
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.